Replies to post #326393 on Amarin Corp Plc (AMRN)

[Jasbg]

Ralph@ Can you please copy/paste text if you have a licence ?

[Whalatane]

Ralphey ...did you see the earlier article linked in your post ( thx for your link by the way )

https://www.bloomberg.com/news/articles/2021-02-08/a-skinny-label-is-worth-a-few-hundred-million-dollars-to-amarin?sref=kwmlAYB7

note

Wall Street applauded the move, with Piper Sandler analyst Yasmeen Rahimi telling investors in a Jan. 26 note that Amarin is in a “strong position to succeed.” Hikma’s generic, the complaint says, has more than 20% of the total volume of Vascepa for Health Net’s business.

Kiwi

[hayward]

ralphey

From bloomburg


The law encourages generic-drug makers to use “skinny labels” for copycat medicines that include only older uses, but not newly-approved ones.

In our case just the fact that the generics prouduce more product then the skinny label is approved for should make us winners

Michael